ロード中...
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates
A licensed vaccine against Ebola virus (EBOV) remains unavailable, despite >11 000 deaths from the 2014–2016 outbreak of EBOV disease in West Africa. Past studies have shown that recombinant vaccine viruses expressing EBOV glycoprotein (GP) are able to protect nonhuman primates (NHPs) from a leth...
保存先:
| 出版年: | J Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5050474/ https://ncbi.nlm.nih.gov/pubmed/27493239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw250 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|